Primary T-cell activation at mucosal sites is of utmost importance for the development of vaccination strategies. T-cell priming after vaginal immunization. with ovalbumin and CpG oligodeoxynucleotide adjuvant as model vaccine formulation. was studied in vivo in hormone-synchronized mice and compared to the one induced by the nasal route. https://www.spidertattooz.com/